Evidence map›Paper›PMID 24726732›Full record

ArticleFEBS letters2014

MIR146A inhibits JMJD3 expression and osteogenic differentiation in human mesenchymal stem cells.

Jessica M Huszar, Christopher J Payne

Open access · bronzeAbstract read
In one paragraph

Article in FEBS letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. The Crucial Role of Epigenetic Modifications in Wharton's Jelly Stem Cells.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. JMJD3: a critical epigenetic regulator in stem cell fate.Cell communication and signaling : CCS · 2021
    Review
  8. [The Role of Histone Demethylase in Osteogenic and Chondrogenic Differentiation of Mesenchymal Stem Cells: A Literature Review].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. JMJD3 as an epigenetic regulator in development and disease.The international journal of biochemistry & cell biology · 2015
    Review
  20. The role of microRNAs in bone remodeling.International journal of oral science · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jessica M HuszarDriskill Graduate Program, Departments of Pediatrics and Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, and Human Molecular Genetics Program, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL 60611, USA.
Christopher J PayneDriskill Graduate Program, Departments of Pediatrics and Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, and Human Molecular Genetics Program, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL 60611, USA. Electronic address: c-payne@northwestern.edu.
Northwestern University · US

Funding

Epigenetic Regulation in Self-Renewing and Differentiating Male Germ CellsR00HD055330 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI PAYNE, CHRISTOPHER JESS · 2010 to 2012
$742k
NICHD NIH HHS R00 HD055330
6 · The paper itself

Abstract

Chromatin remodeling is important for cell differentiation. Histone methyltransferase EZH2 and histone demethylase JMJD3 (KDM6B) modulate levels of histone H3 lysine 27 trimethylation (H3K27me3). Interplay between the two modulators influence lineage specification in stem cells. Here, we identified microRNA MIR146A to be a negative regulator of JMJD3. In the osteogenic differentiation of human mesenchymal stem cells (hMSCs), we observed an upregulation of JMJD3 and a downregulation of MIR146A. Blocking JMJD3 activity in differentiating hMSCs reduced transcript levels of osteogenic gene RUNX2. H3K27me3 levels decreased at the RUNX2 promoter during cell differentiation. Modulation of MIR146A levels in hMSCs altered JMJD3 and RUNX2 expression and affected osteogenic differentiation. We conclude that JMJD3 promotes osteogenesis in differentiating hMSCs, with MIR146A regulating JMJD3.

Indexed as

Cell DifferentiationRNA Interference3' Untranslated RegionsBase SequenceCells, CulturedDown-RegulationEnzyme RepressionHistonesHumansJumonji Domain-Containing Histone DemethylasesMesenchymal Stem CellsMicroRNAsOsteogenesisProtein Binding3' Untranslated RegionsHistonesJumonji Domain-Containing Histone DemethylasesKDM6B protein, humanMicroRNAsMIRN146 microRNA, humanCell differentiationJumonji domain containing 3MicroRNAMIR146AOsteogenesisStem cells

Identifiers

PMID24726732
PMCPMC4083811
OpenAlexW1983459888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.